The global ambulatory surgical equipment market is valued at USD 7.39 billion in 2026 and is expected to reach USD 14.58 billion by 2035, growing at a 7.85% CAGR. North America dominates with 34% market share, while Asia Pacific is the fastest-growing region. Endoscopy and laparoscopy systems lead by product type at 18% share, with compact intraoperative imaging expected to grow fastest. Independent ambulatory surgical centers account for 42% of the market.

The global orthobiologics market is projected to grow from USD 6.68 billion in 2025 to USD 9.52 billion by 2031, with a CAGR of 6.17%. Growth is driven by rising osteoarthritis cases, sports-related injuries, and advancements in regenerative therapies including stem cell therapy and platelet-rich plasma treatments. North America leads the market while Asia-Pacific is the fastest-growing region.

The Portnoy Law Firm has initiated an investigation into possible securities fraud at Zimmer Biomet Holdings following a 15.2% stock price decline on November 5, 2025. The drop occurred after the company reported Q3 2025 net sales of approximately $2 billion and lowered its full-year organic revenue growth forecast from 4.5% to 4.0%, citing weakness in Latin America, emerging markets, and slowdowns in the U.S. revision market for orthopedic procedures.

With 59% of S&P 500 companies reported, Q4 2025 shows 13% EPS growth and 8.8% revenue growth. Big Tech's massive capex spending on AI infrastructure ($185B for Alphabet, $200B for Amazon) has sparked concerns about free cash flow sustainability and SaaS disruption from AI agents. This week's earnings focus shifts to semiconductor and software companies to assess whether AI spending benefits the broader ecosystem or threatens traditional business models.

The global orthopedic implants market is projected to grow from USD 23.50 billion in 2025 to USD 33.20 billion by 2033, expanding at a CAGR of 4.43%. Growth is driven by rising musculoskeletal disorders, aging populations, technological advancements in biomaterials and minimally invasive procedures, and digital orthopedic solutions. However, high implant costs, strict regulatory requirements, and pricing pressures from healthcare providers remain key challenges.

The global arthroscopy devices market is projected to grow from USD 8.8 billion in 2024 to USD 11.8 billion by 2032, driven by rising incidence of joint disorders, sports injuries, aging populations, and technological advancements in minimally invasive surgical procedures. North America leads the market, with Asia-Pacific expected to witness the fastest growth.

Europe's foot and ankle devices market is projected to grow from USD 1.01 billion in 2024 to USD 1.72 billion by 2033 at a CAGR of 6.1%, driven by aging populations, rising musculoskeletal disorders, and advancements in minimally invasive techniques and 3D-printed implants. Key growth factors include expanding hospital and outpatient facility capabilities and Europe's leadership in sports-injury treatment.

The global Pedicle Screw Systems Market is projected to grow from $2.38 billion in 2025 to $3.71 billion by 2033, with a 5.76% CAGR, driven by rising spinal disorder prevalence and technological advancements in spine surgery.

Zimmer Biomet Holdings experienced a significant stock price drop after revealing distributor order cancellations in emerging markets and reducing its revenue forecast, prompting a shareholder investigation into potential securities law violations.

Trex Company reported disappointing Q3 2025 financial results, with net sales 5% below guidance and a sequential revenue decline of 26%. The company revised its 2025 sales growth to flat, causing significant stock price drop and prompting an investor investigation.

The global nailing systems market is projected to grow at a 5.4% CAGR from 2026 to 2032, reaching $654.49 Million by 2032, driven by rising orthopedic trauma cases, technological advancements, and increasing preference for minimally invasive surgeries.

Zimmer Biomet Holdings experienced significant stock price decline after revealing distributor order cancellations in emerging markets and reducing its revenue forecast, prompting a shareholder investigation into potential securities law violations.